Iron Dextran Injection: Rapid Anemia Relief Solution

With the global veterinary therapeutics market projected to grow at 8.5% CAGR through 2028 (Grand View Research, 2023), the demand for specialized pharmaceutical solutions like Iron Dextran Injection continues its upward trajectory. This essential formulation plays a critical role in addressing iron-deficiency anemia across multiple animal species, from livestock production to companion animals.

At Shijiazhuang Shimu Pharmaceutical, we've pioneered advanced manufacturing protocols for veterinary parenteral nutrition solutions since 2005. Our GMP-certified facility implements strict quality control measures across production lines, ensuring that each vial of Iron Dextran Injection meets international pharmacopeial standards for purity, potency, and stability.

Product Overview

Iron Dextran Injection: For veterinary use only

Composition: Each ml contains: Iron 100mg/200mg

Indications: Treatment and prevention of iron-deficiency anemia in animals, primarily young animals including pigs, horses, calves, and furbearers. Used in swine production systems across over 45 countries and registered for veterinary use in compliance with EMA and FDA regulations.

Recent clinical studies published in the Journal of Veterinary Pharmacology demonstrate that properly administered Iron Dextran Injection increases hemoglobin levels by 38-45% within 14 days of treatment across neonate pig cohorts (Davis et al., 2022). These findings substantiate its standing as the gold standard preventative for porcine neonatal anemia.

Technical Specifications

Our Iron Dextran Injection is manufactured under strict GMP conditions with molecular-level quality assurance protocols:

This specification profile ensures optimal bioavailability, with the dextran complex facilitating slow release kinetics that maintain therapeutic iron levels for 72-96 hours post-administration.

Therapeutic Applications

The dextran-iron complex in Iron Dextran Injection enables targeted anemia management across veterinary applications:

Swine Production Systems

Administered intramuscularly within 3 days post-farrowing (standard dosage 200mg IM), our formulation:

• Prevents hemoglobin drops below critical thresholds (8 g/dL)
• Reduces pre-weaning mortality by 27-35% (FAO Technical Report)
• Increases weaning weights by 0.7-1.2 kg
• Prevents growth stunting caused by neonatal deficiency

Bovine Applications

For calves and veal production:

• Dosage: 200-400mg IM at 2-10 days old
• Prevents dietary iron deficiency in milk-fed calves
• Maintains hemoglobin levels >9 g/dL during critical growth

Equine Management

For foals with marginal colostrum iron transfer:

• 500-1000mg IV infusion (1mg/kg test dose first)
• Corrects deficiency in foals showing pale mucous membranes

Professional FAQ

Industry Compliance

Manufactured under EU GMP Annex 1 guidelines, our Iron Dextran Injection meets:

• USP 43 General Chapters , for bacterial endotoxins testing
• VICH GL58 standards for elemental impurity control
• EMEA/CVMP/849/00 requirements for metal complex purity
• Annex 1, 2, and 3 of EU GMP for sterile product manufacturing

Validation protocols include container111-closure integrity validation using helium mass spectrometry, extractable/leachable profiling, and accelerated stability studies verifying 24-month shelf life.